On the run, page-12

All Australian index isn't really followed that much - certainly not in comparison to the ASX200 and the ASX300 - or even the small ords. Canaccord cut their price target from 1.25 to 0.95 on the back of the FDA briefing information.

Extract:

It also worth remembering that of the 6 brokers of which I'm aware that cover it, the recommendations are:

	Column 1	Column 2	Column 3	Column 4
1	Firm	Recommendation	Tgt Px	Date
2	Canaccord Genuity Corp	sell	0.95	09/05/14
3	Bell Potter	buy	2.26	08/29/14
4	Macquarie	underperform	0.65	08/25/14
5	BBY Limited	underperform	0.79	08/22/14
6	Wilson HTM Investment Group	sell	1.06	08/22/14
7	Morgans Financial Limited	reduce	1.22	08/21/14

In other words, apart from that the MIGHTY house of Chas Aitken, there is no target price anywhere near here.

It has previously doubled on the back of a short squeeze, but even given that down 20% does seems a lot for one day, especially when the FDA briefing came out yesterday....